EVP, Chief Financial Officer Lakkaraju Roop Kalyan converted options into 1,078 units of Bio-Rad A Common Stock and covered exercise/tax liability with 420 units of Bio-Rad A Common Stock, increasing direct ownership by 35% to 2,564 units (SEC Form 4)